Filing Details

Accession Number:
0001209191-13-021172
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-04-11 18:04:00
Reporting Period:
2013-04-04
Filing Date:
2013-04-11
Accepted Time:
2013-04-11 18:04:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
754813 Healthwarehouse.com Inc. HEWA Retail-Drug Stores And Proprietary Stores (5912) 222413505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569384 Janice Marra 5 Post Road
Rumson NJ 07760
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-04-04 1,500,000 $0.25 2,213,948 No 4 X Direct
Common Stock Disposition 2013-04-04 250,000 $1.25 1,963,948 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Purchase Warrant Disposition 2013-04-04 1,500,000 $0.00 1,500,000 $0.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-02-01 2018-02-01 No 4 X Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 209,230 Indirect By husband
Common Stock 45,000 Indirect By trust
Common Stock 1,864 Indirect By son
Common Stock 1,575 Indirect By daughter
Common Stock 350 Indirect By son
Common Stock 240 Indirect By daughter
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Act or otherwise, the benefical owner of any equity securities covered by this filing excpet for those shares owned by the reporting person in an individual capacity.
  2. The reporting person exercised a warrrant to purchase 1,500,000 shares of common stock for the original exercise price of $0.25 per share. The reporting person paid the exercise price on a cashless basiss, resulting in the company issuing 1,250,000 shares of common stock to the reporting person.